Page last updated: 2024-08-24

risotilide and Obesity

risotilide has been researched along with Obesity in 1 studies

*Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Itzhaki-Bachar, L; Levin, G; Meyer, R; Weissmann-Brenner, A	1

Other Studies

1 other study(ies) available for risotilide and Obesity

Article	Year
Incidental finding of meconium-stained amniotic fluid in elective cesarean deliveries: Features and perils. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 158, Issue:2 Topics: Adult; Amniotic Fluid; Body Mass Index; Cesarean Section; Female; Humans; Infant, Newborn; Meconium; Obesity; Pregnancy; Pregnancy in Diabetics; Pregnancy Outcome; Retrospective Studies; Sulfanilamides	2022

Article

Year

Incidental finding of meconium-stained amniotic fluid in elective cesarean deliveries: Features and perils.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 158, Issue:2

Topics: Adult; Amniotic Fluid; Body Mass Index; Cesarean Section; Female; Humans; Infant, Newborn; Meconium; Obesity; Pregnancy; Pregnancy in Diabetics; Pregnancy Outcome; Retrospective Studies; Sulfanilamides

2022